The pharmacogenetics DNA panel allows you to examine the patient’s personal genetic profile via blood analysis and, accordingly, it is easier for the doctor to prescribe the appropriate medicine at the correct dosage. The DNA panel can increase the likelihood of treatment success and reduce the risk of hazardous side effects or ineffective treatment.

The pharmacogenetics DNA panel brings together 29 genes involved in the metabolism of more than 200 drugs.

The use of pharmacogenetic testing is particularly valuable for the following medicinal products:

• antidepressants and other psychotropic drugs;
• painkillers/anti-rheumatic drugs;
• anticoagulants/substances that inhibit blood clotting;
• antibiotics, antiviral and antifungal drugs;
• antidiabetes medicines;
• antihypertensive drugs;
• cytostatics;
• proton pump inhibitors/medicines that inhibit gastric acid production;
• statins/excess cholesterol.

The pharmacogenetics profile does not change, i.e. the results of the analysis are applicable for the rest of your life.

You will receive the test results within 23 (twenty-five) working days, in the form of an English language report. The report contains a list of medicines and a classification of recommendations. To interpret the results, we recommend contacting your treating physician or family physician.

Fasting before giving a blood sample is not required.